| n | Age enrolled in our study (month) | Gender (female/male) | Tumor stage | Treatment before serum collection |
---|---|---|---|---|---|
Healthy children | 10 | 41.9 ± 1.7 | 5/5 | – | – |
NB | 20 | 44.5 ± 6.4 | 9/11 | I: 4 II: 9 III: 6 IV: 1 | 13 children: no treatment 7 children: chemotherapy, receiving vincristine, cyclophosphamide, adriamycin, etoposide, and cisplatin |
OMS + NB | 10 | 35.6 ± 9.9 | 5/5 | I: 3 II: 4 III: 3 IV: 0 | 8 children: no treatment 1 child: steroid 1 child: intravenous immune globulin |
Juvenile idiopathic arthritis (JIA) | 10 | 40.8 ± 10.5 | 6/4 | – | 6 children: no treatment 3 children: nonsteroidal anti-inflammatory drugs 1 child: received steroid |
Anti-NDMAR encephalitis | 6 | 54.3 ± 9.9 | 4/2 | – | 2 children: no treatment 4 children: steroid and intravenous immune globulin |